Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery.
Expert Opin Drug Deliv
; 7(5): 577-87, 2010 May.
Article
en En
| MEDLINE
| ID: mdl-20345327
ABSTRACT
IMPORTANCE OF THE FIELD Plasmonic nanoparticles provide a new route to treat cancer owing to their ability to convert light into heat effectively for photothermal destruction. Combined with the targeting mechanisms possible with nanoscale materials, this technique has the potential to enable highly targeted therapies to minimize undesirable side effects. AREAS COVERED IN THIS REVIEW This review discusses the use of gold nanocages, a new class of plasmonic nanoparticles, for photothermal applications. Gold nanocages are hollow, porous structures with compact sizes and precisely controlled plasmonic properties and surface chemistry. Also, a recent study of gold nanocages as drug-release carriers by externally controlling the opening and closing of the pores with a smart polymer whose conformation changes at a specific temperature is discussed. Release of the contents can be initiated remotely through near-infrared irradiation. Together, these topics cover the years from 2002 to 2009. WHAT THE READER WILL GAIN The reader will be exposed to different aspects of gold nanocages, including synthesis, surface modification, in vitro studies, initial in vivo data and perspectives on future studies. TAKE HOME MESSAGE Gold nanocages are a promising platform for cancer therapy in terms of both photothermal destruction and drug delivery.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Sistemas de Liberación de Medicamentos
/
Nanopartículas del Metal
/
Oro
/
Hipertermia Inducida
/
Neoplasias
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Expert Opin Drug Deliv
Asunto de la revista:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Año:
2010
Tipo del documento:
Article
País de afiliación:
Estados Unidos